Your browser doesn't support javascript.
loading
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
Br J Haematol ; 165(4): 497-503, 2014 May.
Article in En | MEDLINE | ID: mdl-24528179

Full text: 1 Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute / Antineoplastic Combined Chemotherapy Protocols / Consolidation Chemotherapy Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute / Antineoplastic Combined Chemotherapy Protocols / Consolidation Chemotherapy Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Year: 2014 Type: Article